908 Devices Inc.

NasdaqGM MASS

908 Devices Inc. Shares (Diluted, Weighted) for the Trailing 12 Months (TTM) ending September 30, 2024: 33,470,944

908 Devices Inc. Shares (Diluted, Weighted) is 33,470,944 for the Trailing 12 Months (TTM) ending September 30, 2024, a 4.38% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

908 Devices Inc. Shares (Diluted, Weighted) for the Trailing 12 Months (TTM) ending September 30, 2023 was 32,065,218, a 3.68% change year over year.
908 Devices Inc. Shares (Diluted, Weighted) for the Trailing 12 Months (TTM) ending September 30, 2022 was 30,926,740, a 38.57% change year over year.
908 Devices Inc. Shares (Diluted, Weighted) for the Trailing 12 Months (TTM) ending September 30, 2021 was 22,318,930, a 23.53% change year over year.
908 Devices Inc. Shares (Diluted, Weighted) for the Trailing 12 Months (TTM) ending September 30, 2020 was 18,067,059.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

NasdaqGM: MASS

908 Devices Inc.

CEO	Dr. Kevin J. Knopp Ph.D.
IPO Date	Dec. 18, 2020
Location	United States
Headquarters	645 Summer Street
Employees	230
Sector	Technology
Industries 3D Printing Big Data Biotechnology Chemicals & Advanced Materials Hardware & Electronics Medical Instruments Petrochemicals Plastics

Description

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Key trends

Past 5 years